Observational study / 2012
Higher dietary glycemic load and carbohydrate intake were linked to worse disease-free survival and mortality in stage III colon cancer patients.
A prospective observational study examined 1011 stage III colon cancer patients who reported dietary intake during and 6 months after adjuvant chemotherapy. Patients in the highest quintile of dietary glycemic load had an adjusted HR for disease-free survival of 1.79 (95% CI = 1.29 to 2.48) compared to the lowest quintile (P trend < .001), with similar links seen for recurrence-free and overall survival. The association differed by body mass index (P interaction = .01): higher glycemic load was linked to worse disease-free survival in overweight or obese patients (BMI ≥ 25 kg/m²; HR = 2.26; 95% CI = 1.53 to 3.32), but not in patients with BMI < 25 kg/m². Increasing total carbohydrate intake was also associated with inferior disease-free, recurrence-free, and overall survival (P trend < .001).
Shows an association, not proof of cause and effect.
- Study type
- Prospective observational study
- Who was studied
- 1011 stage III colon cancer patients reporting dietary intake during and after an adjuvant chemotherapy trial
- What was measured
- Disease-free survival, recurrence-free survival, and overall survival
THE PAPER
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Venook A, Fuchs CS. J Natl Cancer Inst, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.